Vaxart, Inc. (VXRT)
0.4344
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Vaxart Market Cap : 105.49M for Oct. 9, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 09, 2026 | 105.49M |
| October 08, 2026 | 105.51M |
| October 07, 2026 | 104.90M |
| October 06, 2026 | 105.94M |
| October 05, 2026 | 101.99M |
| October 02, 2026 | 106.12M |
| October 01, 2026 | 106.85M |
| September 30, 2026 | 109.28M |
| September 29, 2026 | 109.32M |
| September 28, 2026 | 111.17M |
| September 25, 2026 | 110.45M |
| September 24, 2026 | 109.76M |
| September 23, 2026 | 116.51M |
| September 22, 2026 | 117.64M |
| September 21, 2026 | 119.48M |
| September 18, 2026 | 118.02M |
| September 17, 2026 | 121.39M |
| September 16, 2026 | 115.10M |
| September 15, 2026 | 116.56M |
| September 14, 2026 | 118.99M |
| September 11, 2026 | 117.78M |
| September 10, 2026 | 118.27M |
| September 09, 2026 | 118.60M |
| September 08, 2026 | 122.32M |
| September 04, 2026 | 120.20M |
| Date | Value |
|---|---|
| September 03, 2026 | 119.60M |
| September 02, 2026 | 119.11M |
| September 01, 2026 | 119.72M |
| August 31, 2026 | 123.85M |
| August 28, 2026 | 121.82M |
| August 27, 2026 | 122.22M |
| August 26, 2026 | 122.51M |
| August 25, 2026 | 122.02M |
| August 24, 2026 | 121.54M |
| August 21, 2026 | 125.06M |
| August 20, 2026 | 126.20M |
| August 19, 2026 | 120.88M |
| August 18, 2026 | 120.22M |
| August 17, 2026 | 119.96M |
| August 14, 2026 | 131.98M |
| August 13, 2026 | 135.99M |
| August 12, 2026 | 135.94M |
| August 11, 2026 | 135.32M |
| August 10, 2026 | 139.63M |
| August 07, 2026 | 133.68M |
| August 06, 2026 | 138.42M |
| August 05, 2026 | 143.15M |
| August 04, 2026 | 145.70M |
| August 03, 2026 | 142.44M |
| July 31, 2026 | 130.36M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 326.86M |
| Amgen, Inc. | 224.28B |
| Anika Therapeutics, Inc. | 262.04M |
| BioCryst Pharmaceuticals, Inc. | 2.183B |
| Imunon, Inc. | 5.039M |
Market Cap Related Metrics
| PE Ratio | 2.732 |
| PS Ratio | 0.4261 |
| Price to Book Value | 1.281 |
| Price to Free Cash Flow | 3.103 |
| Price | 0.4344 |
| Earnings Yield | 36.60% |
| Operating PE Ratio | 2.615 |
| Normalized PE Ratio | 2.732 |